The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

109 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-09-30

Study Completion Date

2019-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the possible benefits of a tasteless and sugar free chewing gum as a salivary stimulant for head and neck cancer patients treated with curative intended radiotherapy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparing Over-the-counter Dry Mouth Remedies After Radiation

NCT00595933

Xerostomia

COMPLETED PHASE1

Efficacy of Oral Moisturizing Jelly on Oral Health and Nutrition in Post-radiotherapy Head and Neck Cancer Patients

NCT03035825

Cancer of Head Neck Radiation-Induced Xerostomia Dry Mouth

COMPLETED NA

The Effect of Honey on Xerostomia and Oral Mucositis

NCT01465308

Head and Neck Cancer

COMPLETED PHASE2

A Trial Looking at Treating Dry Mouth After Radiotherapy for Head and Neck Cancer

NCT02941276

Xerostomia Head and Neck Neoplasms

COMPLETED NA

The Effectiveness of a Thyme and Honey Spray for Oral Toxicities

NCT04880148

Cancer of the Head and Neck Xerostomia Oral Mucositis +1 more

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Radiation-induced xerostomia and hyposalivation are frequent side effects after completed treatment for oral and oropharyngeal cancers. This may induce eating and swallowing difficulties, compromised oral hygiene, pain in the mouth, or speech deficiencies. As a consequence, quality of life is often impaired for this group of patients even after completing treatment.

This study hypothesize that chewing gum can stimulate salivary flow from the residual functional salivary glands and thereby improving the patient's oral well-being.

Primary endpoint:

\- To assess whether the difference between the unstimulated and stimulated salivary flow after a one-month period of using chewing gum will result in improved oral well-being.

Secondary endpoint:

* To assess if unstimulated and stimulated salivary flow differs between the two groups of patients
* To evaluate changes in quality of life with EORTC QLQ H\&N-35 for patients using chewing gum
* To evaluate differences in quality of life with EORTC QLQ H\&N-35 between the two groups of patients.

All patients who have received curative intended treatment for oral or oropharyngeal carcinomas at the Department of Oncology, Odense University Hospital, will be invited to participate in the study. If the eligibility criteria are met the patient will be randomized 2:1 to either the intervention arm with chewing gum or the control arm with standard oral care. The study intends to include 210 patients in total. Of these, 140 patients in the intervention arm and 70 in the control arm. Recruitment to the study was initiated in September 2016 and is expected to be completed in July 2018.

The duration of the study is one month from inclusion and randomization to final follow up. For all included patients, saliva samples are collected (unstimulated and stimulated sialometry) and the EORTC QLQ H\&N-35 questionnaire and a xerostomia specific questionnaire are completed. The patients in the control arm are only introduced to chewing gum at the last follow up visit. In the intervention arm, all patients are instructed to use the chewing gum on a daily basis (preferably 5 times a day) and to make notes in a patient diary to document compliance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Head and Neck Cancer Radiation Therapy Complication Xerostomia Hyposalivation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

2:1 randomization in favor of chewing gum (intervention)

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Patients use tasteless and sugar free chewing gum up to 5 times a day for 1 month.

Daily registrations in a patient dairy.

Group Type ACTIVE_COMPARATOR

Chewing gum

Intervention Type DIETARY_SUPPLEMENT

Control

Patients continue with daily routine to relieve oral discomfort. No chewing gum allowed.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Chewing gum

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years of age
* Diagnosed with oral or oropharyngeal carcinoma
* Received curative intended radiation therapy (primary or postoperative), 60-66Gy including concurrent chemotherapy
* Within 6 to 60 months after radiation therapy
* Complains of xerostomia level 1 (according to Danish Head and Neck Cancer group)
* Written informed consent